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with the s isters who own the hos-
pital. 
T he final authority on medico-
mora l matters is not the adminis-
trator or the board of Directors, 
but the local bishop. 
No Retreat 
T he encounter then is imminent. 
see no hint that the bishops are 
about to retreat from the ir posi-
tion o f total opposition to sterili -
zatio n. Dissenting and abstaining 
bisho ps in the 197 I vote are more 
likely to have now joined the vast 
majo rity because, among other 
things, they have had the oppor-
tunity to review their medico-moral 
princ iples during chats with John 
Cardin al Wright on the ir recent 
trips to Rome. 
T he bishops have the ir choice 
Are You Moving? 
of offering women an a lterna ve 
which is not as certa in but jus as 
safe as tubal ligatio n. They cc .ld 
offer their gentle, guiding h nd 
covered with the velvet glove nd 
ins ist that all C atholic wo en 
throughout the country atl nd 
Billings type ovulatio n-mu JS-
te mperature classes in a mas tve 
progra m. There is precedence for 
this in their insistence tl;lat all 
engaged couples attend Cana in-
struction classes before they m; ry. 
Their other a lterna tive Is the -on 
fist approach, as they have • me 
w ith abortion, declaring autor ttic 
excommunication fo r a ny wt tan 
a nd perhaps any physic ian vho 
partic ipates in ster ilizatio n. 
They could ·also smooth vith 
the velvet glove and strike vith 
the iron fis t simultaneously. ~ 
If the next issue of this journal should be delivered to a diff !r-
ent address, please advise AT ONCE. The return postage a td 
cost of remailing this publication is becoming more and m< re 
costly. Your cooperation in keeping us up-to-date with y<. ur 
address will be most helpful. 
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The. Willowbrook Experiments 
Eugene F. Diamond, M.D. 
At a recent meeting of the Amer-
ican College of Physicians, there 
was a student protest during the 
bestowing of the James D. Bruce 
Memorial Award on Dr. Saul Krug-
man for his research on hepatitis at 
the Willowbrook School in New 
York. This was the latest incident 
in an ethica l debate which has fol-
lowed the reve lation in 1971 that 
~r. Krugman had delibera tely in-
Jected retarded children at Willow-
brook with an active strain of hepa-
titis virus as pa rt of an experiment 
directed toward the development 
of active and passive immuniza-
tion against serum hepatitis. 
Willowbrook is the world's la rg-
est institution for the mentally re-
~arded, housing some 5,200 patie nts 
m a sprawling complex of twenty-
seven buildings on 400 acres of 
~Iaten Island. The current census 
ts actually down fro m a peak of 
6,250 and there is evidence that 
the current administration was 
s~riving mightily to improve condi-
tions under the usual conditions 
?f overcrowding and understaff-
Ing which the American citizenry 
has tacitly accepted as standard for 
~he care of the mentally retarded 
10 most states. The spotl ight of a 
press expose was, however, fo-
cused on Willowbrook's incredi bly 
May, 1973 
Dr. Diamond is professor of Pe-
diatrics at Loyola University Stritch 
School of Medicine. He is an as-
sociate editor of Linacre Quarterly 
and winner of the /969 Thomas 
Linacre A ward. 
In this article, Dr. Diamond con-
siders the ethical points raised by 
research on the prevention of viral 
hepatitis at the Willowbrook school 
in New York - specifically experi-
ments involving injection of child-
inmates with an active strain of hepa-
titis. Although a number of points 
are considered, Dr. Diamond notes 
that the central issue is the " right 
to perform a dangerous experi-
ment on an individual when no 
benefit can accrue to that indi vid-
ual." 
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deplorable conditions and allega-
tions of " human warehouses" and 
" Bedlam in 1972" became daily 
headlines in New York and through-
out the country. It was against this 
background of not inappropriate 
emotionalism that Dr. Krugman's 
studies were evaluated. The issues 
raised, however, are cogent and of 
crucial importa nce pa rticularly in 
view of the current medical and 
experimental climate. 
A French-sponsored resolution 
in the U. N. General Assembly 
on December 20, 1971 , stated that 
" The mentally retarded person has 
to the maximum degree of feasi-
bility the same rights as o ther hu-
man beings" - i.e., the right to 
proper medical care, economic 
security, legal safegua rds, a mean-
ingful occupation, freedom from 
abuse or abridgment, and all other 
assistance necessary to enable him 
to develop to his maximum poten-
tia l. A series of United States 
court decisions in recent years 
have underscored the need for a 
"bill of r ights" for the retarded in 
this country. In the 1965 St. Eliza-
beth' s Hospita l Case in Washing-
ton, D. C., it was ruled that the 
retarded must be "cared for and 
trained , not j ust kept in custody." 
T his standard was a lso applied in 
the Pennhurst Case in Pennsylvania 
in 1971. In an Alaba ma case, Fed -
era l Judge Frank Johnson held tha t 
these rights "are present ones and 
must not only be declared but se-
cured at the earliest practicable 
time." 
Three recent class-action suits on 
beha lf of residents of Belchertown 
State School in Massachusetts, Wil-
134 
low brook in New York and I rt-
low School in Alabama have ad 
the effect of circumventing · tte 
legislatures to make better tre 
for the retarded a direct jud ial 
ma ndate. 
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There is, of course, absol 
no evidence that Dr. Krugm8 
any way condoned conditio r 
Willowbrook. (The allegation 
he was " racist" because of the 
dominance of black and . L atir 
idents at Willowbrook is lik 
spurious and unfounded.) Th 
evidence tha t Dr. Krugman wa 
tivated by humanitarian cons 
tions especially in his original 
at Willowbrook using the m 
vaccine. As a result of th i. 
gram, measles was completel) 
icated at Willowbrook with n one 
si ngle case having been rc ' rted 
there since 1963. 
The work of the Krugman roup 
on the natura l history a nd r ven-
tion of vira l he patitis at th Wil-
lowbrook School has been ir ,)fog-
ress s ince 1956. 1- 5 Twer y-fi ve 
thousand serum specimens were 
studied to clarify the inci •ation 
period, natura l history, anl d fec· 
tiveness of gam ma globulin 1 ophy-
la xis on hepa titis. T he discc ~ry of 
Australia antige n by Blumb g and 
associates •;,7 opened a n v era 
in hepatitis research. It wa~ :>hown 
at Willowbrook that hepatit . asso-
cia ted antigen (HAA) wa-. -:onsis-
tently present in sera from atients 
with serum he patitis (MS-2) mt was 
not present in sera from ,,atients 
with infectious hepati tis MS-1?· 
Since gamma globulin prophylaXIS 
was effective only again~t MS-1 
hepatitis, expe riments wen: under-
Li nacre ()uarterlY 
taken to find a method of prophy-
laxis against MS-2 hepatitis which 
has been endemic at Willowbrook 
since 1949. Contra ry to some pre-
vailing . views · about serum hepa-
titis, it was shown that MS-2 hepa-
titis was transmittable by mouth as 
well as by the pare nteral route. 
Studies on active immunization 
were published in July, 197 1. H The 
infectivity of an MS-2 serum was 
established by innocula ting vary-
ing amounts of the serum into 25 
susceptible children. The a ttack 
rate was 100% based on the ap-
pearance of Hepatitis Associated 
Antigen, or 96% based on the de-
velopment of abnormal SGOT lev-
els. A second group of children 
was given the MS-2 serum after one 
or two injections of a boiled, in-
activated prepar~tion of a I : 10 dilu-
tion of MS-2 serum in distilled 
water. Active immunization was 
induced and prevention or modifi-
cation of hepatitis was accomplished. 
All four of the ch ildren who re-
ceived two injections were pro-
tected. Of the children who recei ved 
a single injection, four were pro-
tected and six developed a modi-
fied hepatitis. 
Justification for the experiments 
was that it was considered inevita-
ble that susceptible children would 
be infected in the institution. It 
was alleged that artificial induction 
of hepatitis implied a " therapeutic" 
effect because of " the immunity 
which is conferred." :; Written con-
sent was obtained from a ll pare nts 
of children involved in the study. 
The means by which this becomes 
an " informed" consent are described 
in detail. •; The sequence was: I) 
May, 1973 
The project was discussed wi th par-
ents in an interview with a psychi-
atric social worker. 2) A group ses-
sion was held at the institution with 
the entire study group present, in-
cluding the physicians, to expla in 
the study in deta il. 3) The family 
physician was consulted by parents . 
4) Consent was obtained but could 
be withdrawn at a ny time. 5) No 
chi ld without pare nts or who was 
a ward of the state was innoculated. 
Similar experiments in passive 
immunizatio n with a high-titer type 
specific Hepatitis B immune serum 
globulin were later conducted. 9 
This method proved to be 70% 
effective in protecting against dis-
ease after injection of the MS-2 
serum . 
Editoria l comment in the Jour-
nal of the American Medical A s-
sociation 1o and Yearbook of Med-
icine 11 was uniformly complimen-
tary. It was not until Lancet 12 com-
mented editorially that the ethical 
issues were de lineated. What about 
the rightness of attempting to in-
fect mentally re ta rded children wi th 
hepatitis for experimental purposes? 
Letters to the editor of Lancet 
by Goldby 13 and Shapiro 14 were 
sharply critical o f the experiments. 
Dr. Krugman was given the oppor-
tunity to reply a nd did so, •s again 
a lluding to informed consent a nd 
the inevitability of institutional in-
fection with MS-2. 
The centra l ethica l issue raised 
by these e xpe riments is whether 
it is right to perform a dangerous 
experiment on a n individual when 
no benefit can accrue to that indi-
vidual. In this context, a child ob-
viously requires more protectio n 
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than an adult and a mentally re-
tarded child requires more protec-
tion than a normal child. The issue 
of informed consent is germane, 
but no t determinative. The Krug-
man group points out that, in their 
opinion, their study conforms to 
the World Medical Association 
Draft Code of Ethics on Human 
Experimentation. 5 While it is true 
that The Draft Code does approve 
of the measures used at Willow-
brook to obtain informed con-
sent, it does so only when the 
experiments conducted produce a 
therapeutic result for the individ-
ua l child involved. If, on the other 
hand, the experiments are construed 
to be "solely for the acquisition of 
knowledge" then the code states: 
" Persons retained in mental hospi-
tals or hospitals for mental defec-
tives should not be used for human 
experiment." Surely the part of 
the ir experimentation carried out 
to determine the infectivity of the 
MS-2 serum was "solely for the 
acquisition of knowledge" since 
the development of immunity as 
a result of deliberate infection can-
not legitimately be called a " thera-
peutic" effect. 
Likewise the claim by Krugman, 
tha t the success of his experiments 
among those children who were de-
libe rately challenged after being 
given heat-modified serum and 
hyperimmune serum globulin, 
pro ves a therapeutic effect is open 
to serious question. A thera peutic 
effect cannot be claimed retroactive-
ly or post-facto when a deliberate 
administration of infected serum 
has been carried out. It certainly 
cannot be claimed for those who 
136 
were infected in spite of < ve 
or passive immunization a r it 
cannot be claimed on the ba· of 
the inevitability of infectio by 
an endemic organism. 
The peculiar position taker d i-
torially in the Journal of the r er-
ican Medical A ssociation de ves 
special mention . 16 The pc ion 
take n there apparently is that nee 
the experiments were suet -; fu l 
they were ipso facto ethical. lere 
we do not see the old mor; fa l-
lacy of the end justifyin: the 
means, but a new imp\ tive 
which says tha t success j1 ifies 
the means. The inference i that 
the measures used would 0 1 be 
une thical if they fail ed to o rk. 
This advocacy· of an utterly •rag-
matic standard of ethics is a cent 
but unmistakable trend i the 
public posture of the An ican 
Medical Association. It is emi-
niscent of the " what ·is It d is 
ethical" position taken on a l rtion 
in 1970. 
It would seem o bvious th . for 
the individual chi ld involved 'l the 
Willowbrook experiments, n· so lid 
claim of therapeutic benefit could 
be made in adva nce of the ~ c~di es. 
The studies, the refore, at le< t vio-
lated a time-ho nored pri nc 1le of 
primum non nocere. It is a · o ob-
vious that therapeutic bene! s will 
have resulted both to othc resi-
dents of the Willowbrook ')chool 
as well as society at l arg~ if an 
e ffective hepatitis vaccine b~·comes 
avai lable. As dramatic and as salu-
tary as the possible el imination of 
hepatitis may be, it is by no means 
clea r that it was not achievable 
by a n experiment constructed in 
Linac rc QuarterlY 
some other way. Other vaccines 
have been successfully evaluated 
by the more painstaking and time 
consuming methods involved in 
studying large populations at risk. 
Even if this were the only method 
of finding a means for active and 
passive immunization against hepa -
titis, it still could not be j ustified 
since the end does not justify the 
means. Since the experiments may 
conform to the letter of the 
World Medical Association Draft 
Code of Ethics on Human Experi-
mentation , the need fo r the updat-
ing of the Code is demonstrated . 
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